Aridis Pharmaceuticals Inc. (ARDS) Social Stream
Featured Post From StockTwits About ARDS
$ARDS $RVP New Price Target $10fReCkLeBeCkLe, published June 2, 2020
Patents related to recent modifications to the VanishPoint® syringes and core technology of the VanishPoint® syringes will expire during the years 2028 through 2032. Other patent applications covering inventions applicable to the VanishPoint® syringes are pending. The Company has other technology as well, including the EasyPoint® needle, which made up 7.2% of revenues in 2019. Safest way to use a syringe/needle, in 2020!